QleanAir Holding AB (publ), the premium provider of solutions for clean indoor air, signs an agreement for a new cleanroom with CELLINK worth 7,6 MSEK. CELLINK is the global market leader in 3D bioprinting and bio-inks.
CELLINK, a daughter company of BICO, provides 3D bioprinting technologies, products, and services to create, understand and master biology which enables researchers to culture cells in 3D, print human tissues and organs for personalized treatment, perform drug screening and provide rheological relevant tissue models for testing of cosmetics, personal hygiene, and wound care products. From year end CELLINK will move into new premises in Kallebäck in Göteborg where QleanAir will develop and build a cleanroom. The room will primarily be used for the development and production of reagents such as bio-ink.
— Our move to Kallebäck will be the beginning of a new chapter for our company and is a strategic move in order to reach our business mission and continue to push the boundaries of how 3D bioprinting can contribute to the future of health. In this context the new cleanroom facilities will improve the quality of our products and services. We look forward to working with QleanAir on this important project, says Cecilia Edebo, CEO of CELLINK.
The order value of 7.6 MSEK will be included in the order intake in the third quarter. In addition, there will be a separate service agreement. The clean room team of QleanAir will start working with situation analysis and solution design within short, in close collaboration with the project team from CELLINK. The cleanroom installation will be finished during the first part of 2022.
— We are excited to pave the way for CELLINKs groundbreaking work that is revolutionizing science as we know it. This is yet another confirmation of our strong position within clean room solutions in this market segment, says Christina Lindstedt, CEO of QleanAir.